Dose: 3000 Units
Single Dose: 3000 (3000)
Frequency: As recommended.
Route: SC
Instructions: 1-2 hrs before the procedure, followed by 3000 Units daily for 7 to 10 days.

Certoparina sodica is the derivative of Certoparin. It is of Semi Synthetic origin and belongs to anti-coagulant (low Mol weight heparin). It belongs to Anticoagulants pharmacological group.Its pKa is 2.4.

Certoparin is contraindicated in conditions like Thrombocytopenia,Bleeding.

The severe or irreversible adverse effects of Certoparin, which give rise to further complications include Alopecia, Osteoporosis.Certoparin produces potentially life-threatening effects which include Pulmonary embolism. which are responsible for the discontinuation of Certoparin therapy.The symptomatic adverse reactions produced by Certoparin are more or less tolerable and if they become severe, they can be treated symptomatically, these include Thrombocytopenia, Hypersensitivity reactions.

Certoparin is primarily indicated in conditions like Prevention of thromboembolism.

No data regarding the interactions of Certoparin was found.

Drug should not be given to Pregnant Mothers, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Solutions, liquids Store . Protect from Sunlight, Moisture and Heat.

Certoparin should not be given to patients at serious risk of haemmorhage; patients at risk of include those with haemorrhagic blood disorders, thrombocytopenia, peptic ulcers, CVS disorders, bacterial endocarditis, severe hypertension, oesophageal varices, or patients who have recently undergone surgery at sites where haemorrhage would be at especisl risk. Severe kidney and liver impairment.